BePure supplies nutritional products, clinical services and wellness testing nationwide, selling most of its products and services on a subscription basis, and leading the holistic health and wellness space in New Zealand.
Founded by leading clinical nutritionist Ben Warren, BePure has built a strong brand and an impressive social media following with highly engaged customers who understand the value in BePure's ability to improve their lives.
Our mission is to create a new future of health for New Zealand and across the globe where people are empowered to take back ownership of their health.
Since the brand relaunch in 2015, BePure has educated more than 65,000 people at Ben’s nationwide seminars, supplied thousands of people with BePure nutritional products, supported almost 5,000 clients through the BePure Clinic and launched Eve Health in February 2019 to provide easy access to leading at home wellness testing.
BePure consists of three businesses, each supporting and leveraging from the other to provide numerous inter-company distribution opportunities:
BePure’s strength is in the interlinked nature of the Group that generates a strong cycle of customer education and health products that alleviate issues and promote a healthy lifestyle. Ben Warren is also one of the most popular wellness spokespeople in NZ.
BePure’s mission to create the future of health requires authentic purposeful actions and results. It’s a mission BePure is wholly committed to and this commitment and dedication is what we attribute our success to so far. A reflection of this dedication is found in the commitment to reinvest into new projects that are geared towards effectively supporting more people on their health journeys.
Through the delivery of our education, products and services, we’ve grown our combined revenue from $2.8m in FY16 to $7.5m in FY19 (a 39% CAGR), delivering consistently strong GP margins of between 44-57% and positive EBITDA over the same period. With new equity to execute the strategic growth plan, we believe we can continue on this trajectory, helping more people on their health journeys with our products and services to grow revenues to $35.6m by FY23, delivering $8.8m of EBITDA.
Investment highlights for the BePure opportunity include:
It’s no secret that the world is switching on to the health and wellness movement. The global wellness economy was a USD$4.2 trillion market in 2017. The industry grew by 6.4% annually from 2015 to 2017, nearly twice as fast as global economic growth, with the New Zealand market sharing in this growth.
We see the global growth in the wellness movement being driven by:
"Dietary supplements are becoming more popular with the rapidly ageing population and the trend for maintaining healthier lifestyles. The review period witnessed major growth in dietary supplements due to an increase in consumers taking charge of their own weight and health management, and an acknowledgment that health is fundamentally linked to daily lifestyle choices." - Euromonitor, NZ supplement report 2019.
BePure operates in a relatively diverse set of markets from e-commerce subscription health solutions, to holistic health consultancy work and the retail sale of health supplements.
The global market for health and wellness products and services is growing nearly twice as fast as global economic growth and global trends demonstrate that at-home self testing is a huge growth opportunity for the business within NZ and overseas.
BePure has created and maintains its competitive position through a combination of:
Our vision and strategic objective is to grow our leading New Zealand position in the holistic health and wellness space by introducing more nutritional products that support the needs of our customers and clients, continue to deliver an unrivalled at-home testing service and expand into overseas markets, introducing them to our products and services.
We are seeking to raise $2.5m in equity to invest in stock and new product development, laboratory expansion, scientific R&D and develop a blood testing service partnership so we can capitalise on the organic and international growth opportunities for the business.
Funds raised will go toward the following growth initiatives:
Our forecast revenue growth is mainly driven through expanding our health product distribution overseas, initially in Australia and the USA, along with expanding our at-home testing service both domestically and overseas. These forecasts assume $2.5m of capital is raised to fund the expansion.
|Revenues (BP Health)||2,620||4,670||5,716||7,029||9,987||13,683||19,804|
|Revenues (BP Clinic)||1,507||2,541||1,658||1,660||2,586||3,196||3,861|
|Revenues (Eve Health)||-||-||82||695||3,321||7,572||11,918|
* The forecasts above may change before the offer is opened.
BePure’s mission is to create a new future for health.
BePure is currently championing a niche within this sector, paving the way in scientifically driven holistic health that seeks to work alongside and complement our existing medical model. This focuses on educating and inspiring people to take action on adapting their diets and lifestyles to support their ongoing health, incorporating bioavailable high-quality essential micronutrient support where necessary; testing for optimal health markers; then guiding and supporting people through behavioural change and their ongoing health journeys.
We invite investors to join us in achieving this mission.
If you wish to receive more information about the upcoming capital raise for BePure, please leave your details and an indicative investment amount below. We will be in touch with all interested investors in due course. An Information Memorandum will shortly be available.
Snowball Effect is a New Zealand-based online investing marketplace, that enables New Zealand companies to offer shares to members of the public. Snowball Effect was founded in 2012 and launched in August 2014, after being one of the first to acquire an equity crowdfunding license from the New Zealand Financial Markets Authority (FMA). As of January 2019, over NZ$53 million has been raised on the platform.
Sign up for early access.
Register investment interest